HIV-fertőzés: vizsgálatok itt: Brazília

In Brazília 22 Also abroad 789

22 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Where
Curitiba, Nova Iguaçu, Rio de Janeiro, Salvador, São Paulo
Életkor
12 év and over
People
564 worldwide
Run by
ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00
1. fázisNot yet taking people in Brazília
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
Where
Porto Alegre, Rio de Janeiro
Életkor
18 év to 70 év
People
40 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06987318
2. fázisTaking people
Multiple Interventions With Distinct Anti-reservoir Activities in People on Antiretroviral Treatment
Where
São Paulo
Életkor
18 év to 60 év
People
70
Run by
Federal University of São Paulo
See details and how to joinNCT07903441
2. fázisTaking people
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Where
Porto Alegre, Rio de Janeiro
Életkor
18 év to 70 év
People
48 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05719441
No phaseNot yet taking people in Brazília
Peer-led Community-based PrEP Delivery Among Youth in Brazil
Where
Salvador, São Paulo
Életkor
15 év to 24 év
People
1400
Run by
University of Alabama at Birmingham
See details and how to joinNCT06661356
3. fázisTaking people
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Where
Manaus, Natal, Rio de Janeiro, Salvador
Életkor
15 év to 99 év
People
150
Run by
Johns Hopkins University
See details and how to joinNCT06497465
1/2. fázisTaking people
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Where
Minas Gerais, Porto Alegre, Rio de Janeiro, São Paulo
Életkor
Up to 48 óra
People
1120 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT02140255
2. fázisTaking people
Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
Where
São Paulo
Életkor
18 év to 65 év
People
70
Run by
Federal University of São Paulo
See details and how to joinNCT06805656
No phaseTaking people
Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence
Where
Rio de Janeiro
Életkor
18 év and over
People
3000
Run by
Oswaldo Cruz Foundation
See details and how to joinNCT07772791
3. fázisTaking people
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Where
Boa Vista, Goiânia, Natal, Porto Alegre
Életkor
18 év and over
People
279
Run by
Federal University of Health Science of Porto Alegre
See details and how to joinNCT05814432
3. fázisNot yet taking people in Brazília
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
Where
Manguinhos
Életkor
18 év to 29 év
People
400 worldwide
Run by
HIV Prevention Trials Network
See details and how to joinNCT07658976
No phaseTaking people
BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
Where
Araçatuba, Belo Horizonte, Botucatu, Curitiba, Goiânia, Rio de Janeiro, Santa Maria, Santo André, São Paulo
Életkor
18 év and over
People
743
Run by
Hospital Alemão Oswaldo Cruz
See details and how to joinNCT07118683
No phaseTaking people
Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro
Where
Nova Iguaçu, Rio de Janeiro
Életkor
15 év and over
People
400
Run by
Oswaldo Cruz Foundation
See details and how to joinNCT07584122
No phaseTaking people
Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
Where
Rio de Janeiro
Életkor
18 év and over
People
200
Run by
Oswaldo Cruz Foundation
See details and how to joinNCT07500415
No phaseTaking people
Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training
Where
Rio de Janeiro
Életkor
30 év to 50 év
People
63
Run by
Instituto Nacional de Cardiologia de Laranjeiras
See details and how to joinNCT04512456
No phaseTaking people
ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
Where
Campinas, Florianópolis, Manaus, Nova Iguaçu, Rio de Janeiro, Salvador, São Paulo
Életkor
16 év to 30 év
People
1500
Run by
Oswaldo Cruz Foundation
See details and how to joinNCT07497594
No phaseTaking people
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes
Where
Fortaleza
People
500 worldwide
Run by
University of Michigan
See details and how to joinNCT03087253
No phaseTaking people
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
Where
Londrina
Életkor
40 év and over
People
30 worldwide
Run by
University of Washington
See details and how to joinNCT07105007
No phaseCsak meghívásos
Spironolactone and XPB-1 Integrity in the TFIIH Complex
Where
São Paulo
Életkor
18 év to 60 év
People
12
Run by
University of Sao Paulo General Hospital
See details and how to joinNCT07415811
2. fázisTaking people
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Where
Rio de Janeiro
Életkor
18 év and over
People
130 worldwide
Run by
ANRS, Emerging Infectious Diseases
See details and how to joinNCT05590455
2. fázisTaking people
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
Where
São Paulo
Életkor
18 év and over
People
40
Run by
Code Pharma
See details and how to joinNCT06676410
4. fázisTaking people
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Where
Rio de Janeiro
Életkor
18 év to 59 év
People
400
Run by
Oswaldo Cruz Foundation
See details and how to joinNCT03132311